1. Alderen, R., Hall, M., & Hambley, T. (2006). The discovery and development of cisplatin. Journal of Chemical Education, 83(5), 728–734.
2. American Academy of Audiology (AAA), Durrant, J., Campbell, K., Fausti, S., Guthrie, O., et al. (2009). American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity monitoring. www.Audiology.org, pp. 1–25.
3. American Speech-Language-Hearing Association (ASHA). (1987). Calibration of speech signals delivered via earphones. ASHA, 29(6), 44–48.
4. American Speech-Language-Hearing Association (ASHA). (1988). Guidelines for determining threshold level for speech. ASHA, (30)3, 85–89.
5. American Speech–Language–Hearing Association (ASHA). (1994). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA 36(Suppl. 12), 11–19.